NIH-funded study links adolescent brain differences to increased waist circumference
|
Finding from ABCD Study elucidates neural mechanisms that may underlie early weight gain
NIDAMED News
Vaping, marijuana use in 2019 rose in college-age adults
|
Increases are among the largest in history of national study
Las ratas prefieren la interacción social a la heroína o la metanfetamina
|
Un estudio reciente publicado en Nature Neuroscience muestra que las interacciones sociales pueden generar un profundo efecto en la autoadministración y la recaída en el consumo de drogas y en la respuesta del cerebro a las señales asociadas a estas.
Landmark study of adolescent brain development renews for additional seven years
|
With nearly $290M of new funding for seven years to research institutions around the country, the National Institutes of Health renewed its commitment to the Adolescent Brain Cognitive Development (ABCD) Study, the largest long-term study of brain development and child health ever conducted in the United States.
NIDA Director outlines potential risks to people who smoke and use drugs during COVID-19 pandemic
|
The precarious intersection of the COVID-19 national health emergency and the concurrent epidemic of drug overdose deaths is outlined in the Annals of Internal Medicine this week by Dr. Nora D. Volkow, director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
Vaping of marijuana on the rise among teens
|
Findings from the 2019 Monitoring the Future (MTF) survey demonstrate the appeal of vaping to teens, as seen in the increased prevalence of marijuana use as well as nicotine vaping.
NIH-funded study finds teens prefer mint and mango vaping flavors
|
A new analysis suggests that teens prefer mint and mango as their vaping flavors of choice for e-cigarettes
Healing the altered brains of smokers
|
A study from NIDA’s Intramural Research Program illuminates the roles of the brain’s striatum and habenula in nicotine withdrawal and reward, suggesting that current medications for smoking cessation are not targeting the optimal parts of the brain, leading to ongoing reward processing deficits that could make pleasurable activities less enjoyable.
Racial and Socioeconomic Disparities in Tobacco Smoke Exposure Persist Among U.S. Children
|
The number of children (ages 3 to 11 years) in the United States who are exposed to tobacco smoke decreased steadily from 1999 to 2014. However, childhood tobacco smoke exposure differs among sociodemographic groups.
Machine Learning Applied to Brain Imaging Data Predicts Response to Cocaine Use Disorder Treatment
|
This study demonstrated that functional connectivity among a large number of brain regions predicts patients’ chances of achieving abstinence in treatment for cocaine use disorder.
Nicotine addiction linked to diabetes through a DNA-regulating gene in animal models
|
Researchers have discovered a mechanism in rats that links cigarette smoking and the risk of developing type 2 diabetes.
Marijuana use at historic highs among college-age adults
|
Newly released Monitoring the Future (MTF) survey data on drug use in college-age adults ages 19-22 shows an increase in marijuana use in the past five years, including vaping with marijuana, as well as a significant increase in nicotine vaping.
Rats Prefer Social Interaction to Heroin or Methamphetamine
|
This study showed that rats will forgo heroin and methamphetamine in favor of spending time with another rat. It also highlights the importance of incorporating voluntary choice between drugs and social rewards in drug addiction research.
New findings could lead to reduced replication of the HIV virus
|
In this study, NIDA-funded scientists found that the HIV RNA genome has two previously unknown types of RNA marks.
Por qué las mujeres son más sensibles a la cocaína
|
Las mujeres informan que sienten una euforia más intensa que los hombres al consumir cocaína y se vuelven adictas más rápidamente a esta droga. Hay estudios que han demostrado que la hormona femenina estradiol contribuye a estas diferencias, pero no cómo lo hace. Una nueva investigación, que contó con el apoyo del NIDA, ofrece una posible respuesta.
NIH establishes network to improve opioid addiction treatment in criminal justice settings
|
The National Institutes of Health will award 12 grants to form the Justice Community Opioid Innovation Network (JCOIN) to support research on quality addiction treatment for opioid use disorder (OUD) in criminal justice settings nationwide.
Medical Marijuana Laws and Opioid Overdose Rates
|
A new study underscores the need for additional research on the effect of medical marijuana laws on opioid overdose deaths and cautions against drawing a causal connection between the two.
Co-prescribing naloxone in Medicare Part D increases
|
A study found that overall national rates for naloxone co-prescription along with any opioid among Medicare Part D patients increased from 1.5 per 1000 patients receiving opioid prescriptions in 2016 to 4.6 per 1000 in 2017.
Prescription opioid misuse in high school linked to later heroin use
|
A NIDA-funded study suggests that misuse of prescription opioid pain relievers in high school could be linked to heroin use later in life.
The Brain and our Immune System: Working Together
|
Growing evidence in animal studies documents bidirectional signaling between the brain and immune system in the development of behavioral and physical health problems.
Opioid Dose Variability Associated with Overdose
|
A new study funded by the National Institute on Drug Abuse found that high dose variability increases the odds for an opioid overdose independent of dose alone.
Opioid Overdose Reversal News: FDA-approved naloxone devices produce substantially higher blood levels of naloxone than improvised nasal spray
|
A new study looked at how well the FDA-approved nasal spray and autoinjector compared to the improvised nasal devices, which are not FDA-approved.
The Genius of Chemogenetics
|
Some NIDA-funded scientists have just published findings in the journal Science showing the development of a new, groundbreaking chemogenetics technology for modulating brain function in a remote, precise and ultra-sensitive manner in living subjects.
The brain in pain
|
NIDA-funded researchers identified a critical role for an internal brain opioid network called the dynorphin-kappa opioid receptor (KOR) system.
New toolkit for genomic editing holds promise for addiction research
|
The scientific world has advanced immeasurably by the science of DNA and genetics. Manipulating gene expression to change the way that cells such as neurons function has helped scientists create very specific tools to use for understanding and developing treatments for human diseases.
Higher rates of NAS linked with economic conditions
|
A NIDA-funded analysis of eight states showed a significant association between rates of neonatal abstinence syndrome (NAS) and poor economic conditions.
Cascade of Care model recommended for opioid crisis
|
A team of NIDA-funded scientists has offered a critical look at how to build an improved framework of care for the identification and treatment of people with opioid use disorder (OUD).
Teens using vaping devices in record numbers
|
America’s teens report a dramatic increase in their use of vaping devices in just a single year, with 37.3 percent of 12th graders reporting “any vaping” in the past 12 months, compared to just 27.8 percent in 2017.
National Institute on Drug Abuse to hold teleconference discussing key findings of 2018 Monitoring the Future Survey on teen drug use
|
The National Institute on Drug Abuse (NIDA) will hold a teleconference on Monday, December 17, to discuss the results of the 2018 Monitoring the Future (MTF) survey.
ABCD study completes enrollment, announces opportunities for scientific engagement
|
The National Institutes of Health announced today that enrollment for the Adolescent Brain Cognitive Development (ABCD) Study is now complete and, in early 2019, scientists will have access to baseline data from all ABCD Study participants.